With the analysis among 2,656 patents, we discovered top 449 key players by total patent application. F. Hoffmann-La Roche Ltd., Takeda Pharmaceutical Co., Ltd., Ajinomoto Co., Inc. are dominant in this area. They take 10.58% of the total patent filing.
F. Hoffmann-La Roche Ltd.
Takeda Pharmaceutical Co., Ltd.
Osaka-fu, Japan
Patent: 84
Tokyo-to, Japan
Patent: 82
California, United States
Patent: 79
ZURICH, Switzerland
Patent: 66
Centre of Molecular Immunology
California, United States
Patent: 62
California, United States
Patent: 61
California, United States
Patent: 53
With the analysis among 56 patents, we discovered top 11 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Intarcia Therapeutics, Inc., Obsidian Therapeutics, Inc. are active in this area.
Institut National de la Santé et de la Recherche Médicale
Intarcia Therapeutics, Inc.
California, United States
Patent: 3
Obsidian Therapeutics, Inc.
Massachusetts, United States
Patent: 3
Massachusetts, United States
Patent: 2
New Jersey, United States
Patent: 1
California, United States
Patent: 1
Orionis Biosciences, Inc.
Massachusetts, United States
Patent: 1
Plakous Therapeutics, Inc.
North Carolina, United States
Patent: 1
Hangzhou Biolynx Technology Co. Ltd.
Zhejiang Sheng, China
Patent: 1
California, United States
Patent: 1
With the analysis among related 336 patents applied in the last 5 years. We discover 149 most active companies in this area. The fast-growing F. Hoffmann-La Roche Ltd., Wuhu Interfill Biological Products Industry Research Institute Co., Ltd., Innovent Biologics (Suzhou) Co. Ltd. take 15.77% of patent filing during this period.
F. Hoffmann-La Roche Ltd.
Wuhu Interfill Biological Products Industry Research Institute Co., Ltd.
Anhui Sheng, China
Patent: 18
Innovent Biologics (Suzhou) Co. Ltd.
Jiangsu Sheng, China
Patent: 17
Assistance Publique des Hôpitaux de Paris SA
Hanmi Pharmaceutical Co., Ltd.
Institut National de la Santé et de la Recherche Médicale
Centre of Molecular Immunology
With the analysis among related 336 patents in last 5 years, we discover 109 new entrants. Innovent Biologics (Suzhou) Co. Ltd., Hanmi Pharmaceutical Co., Ltd., TILT Biotherapeutics Oy are the most active new entrants in this area.
Innovent Biologics (Suzhou) Co. Ltd.
Jiangsu Sheng, China
Patent: 17
Hanmi Pharmaceutical Co., Ltd.
Shanghai Hengrui Pharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 6
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 6
JenKem Technology (Tianjin) Co., Ltd.
Tianjin Shi, China
Patent: 5
Novocodex Biopharmaceuticals Co., Ltd.
Zhejiang Sheng, China
Patent: 5
Shanghai Suncadia Pharmaceuticals Co., Ltd.
Institute For Basic Science
Carti (Shanghai) Cell Biotechnology Co., Ltd.
Shanghai Shi, China
Patent: 4
With the analysis among 706 patents, we discovered top 92 universities and scientific research institutions by total patent application. Sorbonne Université, University of Zurich, University of Southern California are dominant in this area. They take 16.71% of the total patent filing.
ZURICH, Switzerland
Patent: 20
University of Southern California
California, United States
Patent: 19
The Johns Hopkins University
New York, United States
Patent: 11
University of Mississippi
Mississippi, United States
Patent: 11
New Hampshire, United States
Patent: 10
University of Mississippi Medical Center
Mississippi, United States
Patent: 10
Minnesota, United States
Patent: 8